SciELO - Scientific Electronic Library Online

vol.31 issue2Ancient urology in the Kingdom of Valencia: OriginsDiverging trends in prostate cancer mortality in the autonomous community of Andalucia (1975-2004) author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google


Actas Urológicas Españolas

Print version ISSN 0210-4806


STEVEN, A.  and  KAPLAN, M.D.. The role of Muscarinic Receptor Antagonists in the Treatment of Men with Lower Urinary Tract Symptoms Secondary to BPH. Actas Urol Esp [online]. 2007, vol.31, n.2, pp.86-91. ISSN 0210-4806.

Use of antimuscarinic agents in male patients with lower urinary tract symptoms (LUTS) secondaryto benign prostatic hyperplasia (BPH) and with symptoms of overactive bladder (OAB) has become increasingly relevant over the last few years. Prescription of these drugs is in conflict with a long-established concept learnt in Medical School: antimuscarinics are contraindicated in patients with BPH. Several factors, however, have placed this issue under constant review. The description of OAB syndrome and the scientific research carried out over recent years have provided epidemiological and pathophysiological data worthwhile reviewing, most importantly in order to understand why a review of such a solidly established concept has been raised. This paper reviews the prevalence of OAB in men with BPH, the role of urodynamics to evaluate men with OAB and the existing evidence on the effectantimuscarinics have in terms of efficacy and safety on male patients with detrusor obstruction and overactivity.

Keywords : Male overactive bladder; Antimuscarinics.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License